New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
07:45 EDTHZNPHorizon Pharma receives additional U.S. patent allowance for Duexis
Horizon Pharma announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Serial No. 13/620,150 entitled "Stable Compositions of Famotidine and Ibuprofen" with claims that cover Duexis tablets. Duexis is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers.
News For HZNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
16:22 EDTHZNPOn The Fly: Closing Wrap
Subscribe for More Information
13:48 EDTHZNPHyperion Therapeutics downgraded to Neutral from Buy at Roth Capital
Subscribe for More Information
12:22 EDTHZNPOn The Fly: Midday Wrap
Subscribe for More Information
11:49 EDTHZNPStreet Check: Hyperion bought after Brean noted takeout potential last month
Subscribe for More Information
11:02 EDTHZNPHyperion Therapeutics downgraded to Hold from Buy at Brean Capital
Brean Capital downgraded Hyperion Therapeutics (HPTX) citing the takeover by Horizon Pharma (HZNP). Brean views the buyout price as "reasonable and fair."
10:12 EDTHZNPHigh option volume stocks
Subscribe for More Information
07:02 EDTHZNPHorizon Pharma to host conference call
Conference call to discuss the acquisition of Hyperion Therapeutics (HPTX) will be held on March 30 at 8 am. Webcast Link
06:04 EDTHZNPHorizon Pharma to acquire Hyperion Therapeutics for $46.00 per share
Subscribe for More Information
06:01 EDTHZNPHorizon Pharma to acquire Hyperion Therapeutics for $46.00 per share
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use